GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chongqing Lummy Pharmaceutical (SZSE:300006) » Definitions » PB Ratio

Chongqing Lummy Pharmaceutical (SZSE:300006) PB Ratio : 3.22 (As of Dec. 12, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Chongqing Lummy Pharmaceutical PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-12), Chongqing Lummy Pharmaceutical's share price is ¥6.27. Chongqing Lummy Pharmaceutical's Book Value per Share for the quarter that ended in Sep. 2024 was ¥1.95. Hence, Chongqing Lummy Pharmaceutical's PB Ratio of today is 3.22.

The historical rank and industry rank for Chongqing Lummy Pharmaceutical's PB Ratio or its related term are showing as below:

SZSE:300006' s PB Ratio Range Over the Past 10 Years
Min: 1.18   Med: 2.78   Max: 15.41
Current: 3.22

During the past 13 years, Chongqing Lummy Pharmaceutical's highest PB Ratio was 15.41. The lowest was 1.18. And the median was 2.78.

SZSE:300006's PB Ratio is ranked worse than
67.91% of 941 companies
in the Drug Manufacturers industry
Industry Median: 2.09 vs SZSE:300006: 3.22

During the past 12 months, Chongqing Lummy Pharmaceutical's average Book Value Per Share Growth Rate was -0.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 11.00% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 0.60% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 1.70% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Chongqing Lummy Pharmaceutical was 50.30% per year. The lowest was -11.50% per year. And the median was 11.00% per year.

Back to Basics: PB Ratio


Chongqing Lummy Pharmaceutical PB Ratio Historical Data

The historical data trend for Chongqing Lummy Pharmaceutical's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chongqing Lummy Pharmaceutical PB Ratio Chart

Chongqing Lummy Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.95 5.15 3.34 1.89 1.89

Chongqing Lummy Pharmaceutical Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.01 1.89 1.57 1.19 1.83

Competitive Comparison of Chongqing Lummy Pharmaceutical's PB Ratio

For the Drug Manufacturers - General subindustry, Chongqing Lummy Pharmaceutical's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chongqing Lummy Pharmaceutical's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chongqing Lummy Pharmaceutical's PB Ratio distribution charts can be found below:

* The bar in red indicates where Chongqing Lummy Pharmaceutical's PB Ratio falls into.



Chongqing Lummy Pharmaceutical PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Chongqing Lummy Pharmaceutical's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=6.27/1.947
=3.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Chongqing Lummy Pharmaceutical  (SZSE:300006) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Chongqing Lummy Pharmaceutical PB Ratio Related Terms

Thank you for viewing the detailed overview of Chongqing Lummy Pharmaceutical's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Chongqing Lummy Pharmaceutical Business Description

Traded in Other Exchanges
N/A
Address
99 Yuma Road, Nan'an District, chongqing, CHN, 401123
Chongqing Lummy Pharmaceutical is a wholly-owned subsidiary of Lai America Pharmaceutical Co., Ltd. and is a professional pharmaceutical sales company in China.
Executives
Lai Wen Executives
Yuan Yuan Supervisors
Qiu Yu Directors, executives
Leng Xue Feng Secretary, Director
Zhang Xiao Xue Supervisors
Wang Ying Director
Zhou Xue Mei Supervisors
Zhao Bin Executives
Tang Xiao Hai Executives
Fu Rong Executives
Li Xian Feng Supervisors
Qiu Wei Director

Chongqing Lummy Pharmaceutical Headlines

No Headlines